Document is current
Any future updates will be listed below
-
Authors
Zemaitis, Kevin J. https://orcid.org/0000-0002-3524-9776
Fulcher, James M. https://orcid.org/0000-0001-9033-3623
Kumar, Rashmi https://orcid.org/0000-0001-8994-5091
Degnan, David J. https://orcid.org/0000-0001-5737-7173
Lewis, Logan A. https://orcid.org/0000-0003-2301-300X
Liao, Yen-Chen https://orcid.org/0000-0002-8124-0457
Veličković, Marija https://orcid.org/0000-0003-3664-5719
Williams, Sarah M. https://orcid.org/0000-0002-0175-466X
Moore, Ronald J. https://orcid.org/0000-0003-2806-2855
Bramer, Lisa M. https://orcid.org/0000-0002-8384-1926
Veličković, Dušan https://orcid.org/0000-0001-7945-9620
Zhu, Ying https://orcid.org/0000-0002-5416-0566
Zhou, Mowei https://orcid.org/0000-0003-3575-3224
Paša-Tolić, Ljiljana https://orcid.org/0000-0001-9853-5457
-
Funding
Funding for this research was provided by:
National Institutes of Health (UG3CA256959)
- License Information
-
More Information
Article History
Received: 16 January 2024
Accepted: 4 September 2024
First Online: 5 March 2025
Declarations
:
: We have complied with all ethical regulations related to this study. All experiments on human samples followed all relevant guidelines and regulations at host institutions and informed consent for remnant tissue collection was acquired in accordance to Institutional Review Board policies at BIOMIC at Vanderbilt University, a TMC associated with the HuBMAP Consortium.
: Not applicable.
: YZ is an employee of Genentech Inc. and shareholder of Roche. All other authors declare that they have no competing interests.
